Background While some studies suggest that the BRAF V600E mutation correlates with a
high-risk phenotype in papillary thyroid microcarcinoma (PTMC), more evidence is …

Abstract Background The BRAF V600E mutation is the most common genetic alteration in
papillary thyroid carcinoma (PTC). In recent studies, the BRAF V600E mutation has been …

Abstract Background The BRAF V600E mutation, which accounts for about 60–80%
papillary thyroid carcinoma (PTC), has been identifiedas a prognostic marker for risk …

Background Previous literatures showed wide range of prevalence of BRAF V600E in
papillary thyroid carcinoma (PTC). The correlation of BRAF V600E mutation with aggressive …

Background Recent studies have shown that BRAFV600E mutation is associated with poor
prognostic factors in papillary thyroid carcinoma (PTC). However, there are no studies about …

Objective Papillary thyroid carcinoma (PTC) accounts for 95% of all thyroid carcinomas. PTC
is an epithelial tumor characterized by the proliferation of follicular cells with distinctive …

Abstract The BRAF V600E mutation is a common genetic alteration in papillary thyroid
carcinoma (PTC) and is associated with some pathological features. The association has …

Abstract Background The BRAF V600E mutation is the most common genetic alteration
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …

Abstract Background The BRAF V600E mutation is a recognised molecular marker in
papillary thyroid cancer (PTC), reported incidence from 30 to 80%. BRAF V600E aberrantly …

Background BRAF V600E mutation is the most common genetic alteration in papillary
thyroid cancer (PTC). We used a mutation-specific antibody for immunohistochemical (IHC) …